한국식품영양과학회지 (Journal of the Korean Society of Food Science and Nutrition)

  • 제42권8호
  • /
  • Pages.1183-1189
  • /
  • 2013
  • /
  • 1226-3311(pISSN)
  • /
  • 2288-5978(eISSN)
한국식품영양과학회 (The Korean Society of Food Science and Nutrition)
권호 표지
DOI QR코드

DOI QR Code

굴 패각 추출물이 Papain으로 유도된 골관절염 C57BL/6J Mice에 미치는 영향

Effects of Oyster Shell Extract on Papain-induced Osteoarthritis in C57BL/6J Mice

  • Lee, Se-Young (Dept. of Food Science and Nutrition, Pusan National University) ;
  • Kim, Hak-Ju (Seojin Biotech Co., Ltd.) ;
  • Han, Ji-Sook (Dept. of Food Science and Nutrition, Pusan National University)
  • 투고 : 2013.02.15
  • 심사 : 2013.07.17
  • 발행 : 2013.08.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

연구에서는 굴 패각 추출물이 papain으로 유도된 골관절염 동물 모델에 미치는 영향을 살펴보았다. 8주령의 C57BL/6J 마우스 우측 슬관절강에 papain $6{\mu}L$를 투여하여 골관절염을 유발하였다. 실험군은 각 군당 체중이 고르게 8마리씩 배정하여 총 다섯군으로 분류하였다. 정상군은 우측 슬관절강에 생리식염수 $6{\mu}L$ 주사하고 20일간 1일 1회 생리식염수 0.2 mL씩 경구투여 하였다. 대조군, 약물투여군, 굴 패각 추출물 투여군은 골관절염을 유발 후 각각 생리식염수, diclofenac sodium 2 mg/kg/bw, OSE 100, 200 mg/kg/bw를 20일 동안 매일 1회 정해진 시간에 경구투여 하였다. 실험기간 동안 체중을 측정하였으며, 실험 20일에 부검하여 슬관절의 병리조직학적 관찰, 관절연골 내 proteoglycan 함유율, 골관절염 지수의 변화, 혈액내 TNF-${\alpha}$, IL-$1{\beta}$, IL-6 함량을 측정하였다. 체중은 실험기간 동안 모든 개체 간의 유의적 차이가 없었다. 관절연골 내 proteoglycan 함유율은 DS 및 OSE 투여군이 papain 투여 대조군보다 유의성(P<0.05)있게 높았으며, 특히 OSE-200 투여군은 약물 투여군과 유사한 proteoglycan 함유율을 나타냈다. H&E 염색을 통하여 관찰한 결과, 골관절염이 유발된 마우스에 굴 패각추출물을 경구 투여하였을 때 관절연골의 파괴와 골 침식 등 연골의 변성이 약물 처리군과 유사한 것을 보아 굴 패각 추출물이 골관절염 치료에 효과가 있는 것을 확인할 수 있었다. 병리조직학적으로 골관절염 지수는 DS 및 OSE 투여군이 papain 투여 대조군보다 유의성(P<0.05) 있게 낮았으며, OSE-200 투여군이 OSE-100 투여군보다 낮았다. 혈액 내 TNF-${\alpha}$, IL-$1{\beta}$, IL-6 함량은 papain 투여 대조군이 정상군에 비해 유의적(P<0.05)으로 증가하였으며, DS 및 OSE 투여군은 대조군보다 유의성(P<0.05) 있게 낮았다. 특히 TNF-${\alpha}$ 및 IL-6 함량은 OSE-200 투여군이 약물 투여군과 유사한 감소 효과를 나타내었다. 이와 같은 결과는 굴 패각 추출물이 papain으로 유도된 골관절염에서 연골의 변성을 줄이고 염증을 억제함으로써 골관절염 치료에 효과가 있는 것으로 사료된다. 굴 패각은 탄산칼슘이 풍부하기 때문에 골관절염 개선에 효과가 있는 것으로 사료되나, 굴 패각 추출물 중 어떠한 기능성 물질이 골관절염 개선 효과를 나타내었는지에 대해 향후 심도 있는 연구가 필요하다.

We investigated the effects of oyster shell extract (OSE) on papain-induced osteoarthritis in C57BL/6J mice. Osteoarthritis was induced in mice by a papain injection into the knee joint. The mice were divided into a total of five groups (n=8). The normal group was untreated, whereas the papain group (negative control) was induced with osteoarthritis and treated with water daily. The papain+DS group (positive control) was treated with diclofenac sodium. Papain+OSE groups were treated with OSE concentrations of 100 and 200 mg/kg/bw for 20 days. Proteoglycan content in articular cartilage was analyzed through safranine-O fast green staining and H&E staining. The histopathological changes in cartilage were measured by the Rudolphi score approach. The contents of tumor necrosis factor-${\alpha}$ (TNF-${\alpha}$), interleukin (IL)-$1{\beta}$, and IL-6 in plasma were analyzed by the ELISA method. After experiments, body weights of the treated groups were not significantly different compared with the normal group. Cartilage loss and joint instability significantly improved in a dose-dependent manner in the OSE-treated group compared with the papain group (P<0.05). Proteoglycan content was significantly higher in the OSE-treated group than the papain group (P<0.05). Osteoarthritis scores of the OSE-treated group were significantly decreased compared with the papain group (P<0.05). TNF-${\alpha}$, IL-$1{\beta}$, and IL-6 content in the plasma of the papain+OSE treated groups significantly decreased in a dose-dependent manner compared with the papain group (P<0.05). These results suggest that OSE treatment might have anti-arthritic effects on papain-induced osteoarthritis in C57BL/6J mice.

키워드

참고문헌

  1. Yuan GH, Masuko-Hongo K, Kato T, Nishioka K. 2003. Immunologic intervention in the pathogenesis of osteoarthritis. Arthritis Rheum 48: 602-611. https://doi.org/10.1002/art.10768
  2. Eom DU, Lee SW, Bea NJ. 2005. Human resource management in the period of ageing and low growth. Report on research of SERI. Korea.
  3. Martel-Pelletier J. 2004. Pathophysiology of osteoarthritis. Osteoarthritis Cartilage 12: S31-S33. https://doi.org/10.1016/j.joca.2003.10.002
  4. Lee YJ. 2004. Medical treatment of osteoarthritis. Korean J Med 67: 564-567.
  5. Bea SC, Corzillius M, Kuntz KM, Liang MH. 2003. Cost-effectiveness of low dose corticcosteroids veusus non-steroidal anti-inflammatory drugs and COX-2 specific inhibitors in the long-term treatment of rheumatoid arthritis. Rheumatology(Oxford) 42: 46-53. https://doi.org/10.1093/rheumatology/keg029
  6. Yoh SB, Sul JU, Shin MS. 2011. Research trends on the treatment of knee osteoarthritis in Korean medicine. Korean J Acupuncture 28: 139-155.
  7. Won CH, Choi ES, Hong SS. 1999. Efficacy of bee venom injection for osteoarthritis patients. J Korean Rheum Assoc 6: 218-226.
  8. Han SC, Ryu JS, Lee KY, Kim DM, Choi CS. 2003. A study on the microencapsulation of DHA and antioxidant effect. J Res Institute Catalysis 24: 81-90.
  9. Park SJ, Kang JY. 2005. Preparation and characterization of calcium alginate microcapsules by emulsification-internal gelation. Polymer Korea 29: 369-374.
  10. Nishimune T, Sumimoto T, Yakusiji T, Kunita N, Ichikawa T, Doguchi M, Nakahara S. 1991. Determination of total dietary fiber in Japanese foods. J Assoc Off Anal Chem 74:350-359.
  11. Mori B, Kusima K, Iwasaki T, Omiya H. 1981. Dietary fiber content of seaweed. Nippon Nogeikagaku Kaishi 55: 787-791. https://doi.org/10.1271/nogeikagaku1924.55.787
  12. Ministry for Food, Agriculture, Forestry and Fisheries. 2010. Development of utilization and Korean medicine material of functional marine product by nano-enzyme techniques. Korea.
  13. Rudolphi K, Gerwin N, Verziji N, van der Kraan P, van den Berg W. 2003. Pralnacasan, an inhibitor of interleukin-1${\beta>$ converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteoarthritis Cartilage 11: 738-746. https://doi.org/10.1016/S1063-4584(03)00153-5
  14. Kim JD. 1990. The effects of cationic lon on proteoglycan synthesis in bovine articular cartilage. PhD Dissertation. Korea University, Seoul, Korea,
  15. An HJ, Lee CK, Park JH, Kim KH, Lee WR, Park IY, Han SM, Lee KG, Park KK. 2012. Effects of bee venom on papain-induced osteoarthritis in an animal model. Kor J Pharmacogn 43: 167-172.
  16. Lee JM. 2011. Effects of Jakyakkamchobuja-tang on papain- induced osteoarthritis in mice. PhD Dissertation. Daejeon University, Daejeon, Korea.
  17. Kikuchi T, Sakuta T, Yamaguchi T. 1998. Intra-articular injection of collagenase induces experimental osteoarthritis in mature rabbits. Osteoarthritis Cartilage 6: 177-186. https://doi.org/10.1053/joca.1998.0110
  18. Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. 2007. New therapies for treatment on rheumatoid arthritis. Lancet 370: 1861-1874. https://doi.org/10.1016/S0140-6736(07)60784-3
  19. Vilcek J, Lee TH. 1991. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple action. J Biol Chem 266: 7313-7316.
  20. Hulejova H, Baresova V, Klezl Z, Polanska M, Adam M, Senolt L. 2007. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine 38: 151-156. https://doi.org/10.1016/j.cyto.2007.06.001
  21. Jin SY, Kang SS, Lee DW, Lim SJ, Yoon YH, Lee BI. 2001. Expression of matrix metalloproteinase (MMP)-1, MMP-3 nitrotyrosine and apoptosis in articular cartilage of human osteoarthritis. Korean J Pathol 35: 319-329.
  22. Ahmed ST, Ivashkiv LB. 2000. Inhibition of IL-6, IL-10 signaling and star activation by inflammatory and stress pathways. J Immunol 165: 5227-5237. https://doi.org/10.4049/jimmunol.165.9.5227
  23. Scheinecker C, Redlich K, Smolen JS. 2008. Cytokines as therapeutic targets: advances and limitations. Immunity 28:440-444. https://doi.org/10.1016/j.immuni.2008.03.005